United States
Germany
Japan
United Kingdom
China
CD79B mouse monoclonal antibody,clone OTI3E3, Biotinylated
| Applications | WB |
| Reactivities | Human |
Antibodies
Carrier-free (BSA/glycerol-free) CD79B mouse monoclonal antibody,clone OTI3E3
| Applications | WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) CD79B mouse monoclonal antibody,clone OTI2H8
| Applications | WB |
| Reactivities | Human |
CD79B mouse monoclonal antibody, clone AT105-1, Purified
| Applications | FC, IP, WB |
| Reactivities | Human |
CD79B mouse monoclonal antibody, clone AT105-1, Purified
| Applications | FC, IP, WB |
| Reactivities | Human |
Anti-CD79b Reference Antibody (polatuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Cynomolgus |
Anti-CD79b Reference Antibody (polatuzumab vedotin-piiq)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-CD79b Reference Antibody (iladatuzumAb)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-CD79b Reference Antibody (Iladatuzumab vedotin)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
CD79B mouse monoclonal antibody, clone CB3-1, Purified
| Applications | FC, IHC, IP |
| Reactivities | Human |
CD79B rat monoclonal antibody, clone AT107-2, Purified
| Applications | ELISA, FC, IP, WB |
| Reactivities | Canine, Human, Mouse, Porcine, Rat |
CD79B mouse monoclonal antibody,clone OTI3E3
| Applications | WB |
| Reactivities | Human |
CD79B mouse monoclonal antibody,clone OTI2H8
| Applications | WB |
| Reactivities | Human |
CD79B rat monoclonal antibody, clone AT107-2, FITC
| Applications | FC |
| Reactivities | Canine, Human, Mouse, Porcine, Rat |
CD79B rat monoclonal antibody, clone AT107-2, Purified
| Applications | ELISA, IP, WB |
| Reactivities | Canine, Human, Mouse, Porcine, Rat |
